Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions around the article are characterized by a focus on detailed trial data and long-term survival rates, such as mentioning the 15-year survival figures from COURAGE. Phrases like 'spin' and references to specific data points reflect a critical tone and active engagement with the scientific content, illustrating how users are deeply analyzing the significance of PCI's long-term benefits.
Most discussions agree that the long-term benefits of PCI are limited, referencing the COURAGE trial data and emphasizing that PCI does not significantly improve survival over medical therapy alone.
Participants show moderate interest, engaging with detailed trial results and long-term follow-up data, rather than broad or superficial discussions.
Conversations include references to specific datasets, trials, and statistical findings, indicating active weighing of evidence and implications.
The discussion appears to influence opinions about clinical decision-making and guidelines, highlighting the importance of the findings in treatment choices.
The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 years > https://t.co/WqeHnzIV1l #aha19
@djc795 @bogdienache @boback @BobDreyfuss2017 @iamritu @mad_sters @ProfDFrancis @rallamee @DrJHoward @mshunshin @MikeTPhD @drjohnm @rwyeh @imperialcollege Then you would have used the COURAGE 10-year data which is 53% of the original cohort? https://t.co/IfZmfK5C0H
@ajaykirtane @webmd11 P.P.P.S. Ha! I was right! 15-year survival after TKR 66.6%. COURAGE 15-year survival was 75% in both arms. Now tell me which disease is more deadly! (I jest, of course) https://t.co/WzTiNk2f6J https://t.co/Sco5FJObON
A similar publication with long-term #COURAGE follow-up was published in the @nejm in 2015, but did not focus on the number of lesions or quantifying severity of ischemia on prognosis. https://t.co/X7pwAAWoDK
RT @drjohnm: The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 yea…
RT @drjohnm: The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 yea…
This video discusses whether PCI prolongs survival in patients with stable ischemic heart disease, highlighting recent research findings that show no significant difference in long-term survival between PCI plus medical…
This video explores whether stents improve long-term survival for patients with stable ischemic heart disease, based on the COURAGE trial's extended follow-up showing no significant survival benefit over medical therapy…
The COURAGE Trial https://t.co/wT8OrcKQ4h via @YouTube
@djc795 @bogdienache @boback @BobDreyfuss2017 @iamritu @mad_sters @ProfDFrancis @rallamee @DrJHoward @mshunshin @MikeTPhD @drjohnm @rwyeh @imperialcollege Then you would have used the COURAGE 10-year data which is 53% of the original cohort? https://t.co/IfZmfK5C0H
@ajaykirtane @webmd11 P.P.P.S. Ha! I was right! 15-year survival after TKR 66.6%. COURAGE 15-year survival was 75% in both arms. Now tell me which disease is more deadly! (I jest, of course) https://t.co/WzTiNk2f6J https://t.co/Sco5FJObON
RT @drjohnm: The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 yea…
RT @drjohnm: The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 yea…
RT @drjohnm: The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 yea…
RT @drjohnm: The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 yea…
RT @drjohnm: The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 yea…
RT @drjohnm: The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 yea…
RT @drjohnm: The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 yea…
RT @drjohnm: The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 yea…
RT @drjohnm: The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 yea…
The talk about crossing curves and the possibility of long-term benefit from PCI is spin. See results of Courage up to 15 years > https://t.co/WqeHnzIV1l #aha19
A similar publication with long-term #COURAGE follow-up was published in the @nejm in 2015, but did not focus on the number of lesions or quantifying severity of ischemia on prognosis. https://t.co/X7pwAAWoDK
JM
LC
YP
BZ
DB
R
PM
FB
PA
RF
KF
GW
AM